active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/YXN0cmF6ZW5lY2EuY29t/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/YXN0cmF6ZW5lY2EuY29t/images/2025-04-04_logo.svg
cik: 0000901832
composite_figi: BBG000BZ0DK8
currency_name: usd
description: A merger between Astra of Sweden and Zeneca Group of the United Kingdom
    formed AstraZeneca in 1999. The firm sells branded drugs across a number of major
    therapeutic areas, including oncology (about 40% of total revenue), cardiovascular,
    renal, and metabolic (25%), rare disease (17%), and respiratory and immunology
    (15%). The majority of sales comes from international markets, with the United
    States representing close to one third of its sales.
homepage_url: https://www.astrazeneca.com
list_date: '1993-05-18'
locale: us
market: stocks
market_cap: 233590199061.84
name: AstraZeneca PLC
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG001SB80N8
share_class_shares_outstanding: 3101365160
ticker: AZN
ticker_root: AZN
total_employees: 94300
type: ADRC
weighted_shares_outstanding: 3100480476
